Phage display identifies an Eastern equine encephalitis virus glycoprotein E2-specific B cell epitope.

Area of Science:

• Virology
• Immunology
• Molecular Biology

Background:

• Eastern equine encephalitis virus (EEEV) is a significant public health concern.
• The E2 glycoprotein is a key target for neutralizing antibodies.
• Developing specific diagnostic and vaccine strategies requires detailed epitope mapping.

Purpose of the Study:

• To identify and characterize a linear B-cell epitope on the EEEV E2 glycoprotein.
• To assess the specificity of the identified epitope against related alphaviruses.
• To generate reagents for potential diagnostic and vaccine development.

Main Methods:

• Screening of a phage-displayed random 12-mer peptide library using a specific monoclonal antibody (mAb 7C11).
• Synthesis of EEEV E2 glycoprotein epitope peptides and corresponding peptides from related alphaviruses.
• Immunological assays including ELISA to confirm antibody binding and specificity.

Main Results:

• A linear B-cell epitope with a consensus binding motif (L/F-E/R-Y-T-W-G/R-N-H/W-P) was identified on the EEEV E2 glycoprotein.
• A synthesized polypeptide (residues 321-332) containing the motif confirmed epitope binding.
• The monoclonal antibody and murine antisera showed strong reactivity with EEEV peptides but no reactivity with Western equine encephalitis virus (WEEV) or Venezuelan equine encephalitis virus (VEEV) peptides.

Conclusions:

• A specific linear B-cell epitope on the EEEV E2 glycoprotein has been successfully identified.
• The identified epitope is specific to EEEV, distinguishing it from WEEV and VEEV.
• The findings provide valuable knowledge and reagents for differential diagnosis and the development of EEEV-specific epitope-based vaccines.